Skip header and navigation

2 records – page 1 of 1.

What is the Oncotype DX test?

https://libcat.nshealth.ca/en/permalink/chpams37365
Nova Scotia Health. Cancer Care Program. Halifax, NS: Nova Scotia Health Cancer Care Program , 2023.
Pamphlet Number
4047
Available Online
View Pamphlet
Oncotype DX is a test panel used to help predict whether a patient with breast cancer could benefit from chemotherapy in addition to hormone therapy. The panel tests multiple specific tumor genes and generates a score which helps predict response to chemotherapy. The genes tested are those expressed by the tumor, not genes that you inherit from your parents our pass along to your children. This pamphlet gives information to help you decide if the Oncotype Dx test is right for you.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health. Cancer Care Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Cancer Care Program
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Breast Neoplasms - diagnosis
Genes, Neoplasm
Genetic Testing
Subjects (LCSH)
Breast--Cancer--Diagnosis
Cancer genes
Human chromosome abnormalities--Diagnosis
Specialty
Cancer Care
Breast Disease
Abstract
Oncotype DX is a test panel used to help predict whether a patient with breast cancer could benefit from chemotherapy in addition to hormone therapy. The panel tests multiple specific tumor genes and generates a score which helps predict response to chemotherapy. The genes tested are those expressed by the tumor, not genes that you inherit from your parents our pass along to your children. This pamphlet gives information to help you decide if the Oncotype Dx test is right for you.
Responsibility
Prepared by: Nova Scotia Health Cancer Care Program
Pamphlet Number
4047
Less detail

Chimeric antigen receptor t-cell therapy

https://libcat.nshealth.ca/en/permalink/chpams37609
Nova Scotia Cell Therapy and Transplant Program. Halifax, NS: Nova Scotia Health Cancer Care Program , 2022.
Pamphlet Number
4035
Available Online
View Pamphlet
This booklet is a guide to help you better understand chimeric antigen receptor T-cell therapy (CAR T-cell therapy). Topics include what CAR T-cell therapy is, enrollment in the program, T-cell collection, monitoring/bridging therapy, chemotherapy (lymphodepletion), CAR T-cell infusion, monitoring post-cell infusion, key inpatient discharge information, information about long term follow-up care and care at home, ongoing side effects, and information for the CAR T-cell care partner. Information…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Cell Therapy and Transplant Program
Alternate Title
CAR t-cell therapy
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Cancer Care Program
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document (44 p.) : digital, PDF file
Subjects (MeSH)
Neoplasms - therapy
Immunotherapy, Adoptive
Subjects (LCSH)
Cancer--Treatment
T-cell receptor genes
Immunotherapy
Specialty
Cancer Care
Abstract
This booklet is a guide to help you better understand chimeric antigen receptor T-cell therapy (CAR T-cell therapy). Topics include what CAR T-cell therapy is, enrollment in the program, T-cell collection, monitoring/bridging therapy, chemotherapy (lymphodepletion), CAR T-cell infusion, monitoring post-cell infusion, key inpatient discharge information, information about long term follow-up care and care at home, ongoing side effects, and information for the CAR T-cell care partner. Information about Cell Therapy Transplant Program policies, the Medical Day Unit and Hematology Clinic, shingles, recommended vaccinations, and emotional support resources is included. A map of the QEII Health Sciences Centre Victoria General site is provided.
Responsibility
Prepared by: Nova Scotia Cell Therapy and Transplant Program
Pamphlet Number
4035
Less detail